Dapivirine Vaginal Ring 25 mg H-W-2168

Name of the medicinal productDapivirine Vaginal Ring 25 mg
Opinion holder

International Partnership for Microbicides Belgium AISBL
Square de Meeus 38/40
1000 Brussels
Belgium

Active substancedapivirine
International non-proprietary name or common namedapivirine
Pharmaco-therapeutic group

Other antiinfectives and antiseptics

ATC code

G01AX17

Therapeutic indicationReducing the risk of HIV-1 infection via vaginal intercourse in HIV-uninfected women 18 years and older in combination with safter sex practices when oral PrEP is not/cannot be used or is not available.
Orphan medicinal product designation dateNot applicable

Documents

*This document includes:

Annex I - Summary of product characteristics
Annex IIA - Manufacturer responsible for batch release
Annex IIB - Recommendations to the opinion holder - conditions of use
Annex IIIA - Labelling
Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.

Topics

How useful was this page?

Add your rating
Average
1 rating